Development Level

Tbio 3 | 10,625
Tchem 1 | 1,890

IMPC Term

preweaning lethality, complete... 2 | 633
aorta dilation 1 | 3
decreased mean platelet volume 1 | 12
increased startle reflex 1 | 38
oligodactyly 1 | 14

Disease

lung cancer 3 | 4,466
ovarian cancer 3 | 8,484
Carcinoma 2 | 2,147
atypical teratoid / rhabdoid tumor 2 | 4,369
cutaneous lupus erythematosus 2 | 1,056
medulloblastoma, large-cell 2 | 6,234
osteosarcoma 2 | 7,933
psoriasis 2 | 6,685
Age related macular degeneration 1 | 84
Blepharophimosis 1 | 17
Breast cancer 1 | 3,094
Cancer 1 | 2,346
Cocaine-Related Disorders 1 | 88
Connective tissue cancer 1 | 9
Down syndrome 1 | 548
Epilepsy 1 | 346
FG syndrome 1 | 17
Goldberg-Shprintzen syndrome 1 | 8
Gout 1 | 93
Hepatitis B, Chronic 1 | 15
Huntington's disease 1 | 72
IGA Glomerulonephritis 1 | 454
Idiopathic Membranous Glomerulonephritis 1 | 18
Infertility 1 | 163
Intellectual disability 1 | 573
Kaposi's sarcoma 1 | 20
Kleefstra syndrome 1 | 9
Leiomyoma 1 | 25
Leiomyosarcoma 1 | 19
Lujan Fryns syndrome 1 | 3
Lung Neoplasms 1 | 171
Lupus erythematosus 1 | 80
Macular degeneration 1 | 41
Mammary Neoplasms 1 | 410
Neoplasm Metastasis 1 | 138
Nephroblastoma 1 | 45
Ohdo syndrome 1 | 6
Ohdo syndrome, Maat-Kievit-Brunner type 1 | 1
Opitz-GBBB syndrome 1 | 19
Phyllodes Tumor 1 | 5
Prostate cancer 1 | 172
Prostatic Neoplasms 1 | 471
Seizures 1 | 95
Smooth muscle tumor 1 | 12
Spontaneous ocular nystagmus 1 | 4
Tularemia 1 | 22
Uterine fibroid 1 | 29
Vestibular nystagmus 1 | 7
adrenocortical carcinoma 1 | 1,427
astrocytoma 1 | 1,493
chronic lymphosyte leukemia 1 | 232
cystic fibrosis 1 | 1,665
fibroadenoma 1 | 557
glioblastoma 1 | 5,572
group 3 medulloblastoma 1 | 2,254
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
hepatocellular carcinoma 1 | 532
interstitial cystitis 1 | 2,299
intraductal papillary-mucinous neoplasm (IPMN) 1 | 3,289
invasive ductal carcinoma 1 | 2,950
lung adenocarcinoma 1 | 2,713
lung carcinoma 1 | 2,844
medulloblastoma 1 | 1,524
mucosa-associated lymphoid tissue lymphoma 1 | 480
non-small cell lung cancer 1 | 2,798
oligodendroglioma 1 | 2,849
pediatric high grade glioma 1 | 2,712
pilocytic astrocytoma 1 | 3,086
pituitary cancer 1 | 1,972
posterior fossa group A ependymoma 1 | 1,511
posterior fossa group B ependymoma 1 | 1,530
primary Sjogren syndrome 1 | 789
primitive neuroectodermal tumor 1 | 3,031
sarcoidosis 1 | 358
subependymal giant cell astrocytoma 1 | 2,287
tuberculosis 1 | 1,557
ulcerative colitis 1 | 2,087

Tissue

Blood and immune system 4 | 17,995
Cardiovascular System 4 | 17,958
Digestive Tract 4 | 18,473
Endocrine System 4 | 18,512
Female tissues 4 | 18,647
Liver and Pancreas 4 | 18,136
Male tissues 4 | 17,969
Nervous System 4 | 18,561
Respiratory system 4 | 17,484
Skin and soft tissues 4 | 18,115
Urinary Tract 4 | 18,444

Target Family

Enzyme 1 | 4,146
Epigenetic 1 | 242
Non-IDG 1 | 11,971
Transcription Factor 1 | 1,400

Grant Application

1R01MH085320-01A1 4 | 4
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Mediator of RNA polymerase II transcription subunit 12 MED12 Tbio Enzyme -2.53670 368.8 90
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.26799 140.7 401
Histone-lysine N-methyltransferase EHMT2 EHMT2 Tchem Epigenetic -2.40965 285.5 240
RE1-silencing transcription factor REST Tbio Transcription Factor -2.39451 228.3 160